3SBio (NASDAQ:SSRX) Stock Price, News, Analysis & History

$16.59 0.00 (0.00 %)
(As of 03/22/2018 04:00 PM ET)
Previous Close$16.59
Today's RangeN/A
52-Week Range$10.15 - $16.70
Average Volume149,084 shs
Market Capitalization$366.10 million
P/E Ratio22.73
Dividend YieldN/A


3SBio logo3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub.

Receive SSRX News and Ratings via Email

Sign-up to receive the latest news and ratings for SSRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biopharmaceuticals


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio22.7260273972603
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

3SBio (NASDAQ:SSRX) Frequently Asked Questions

What is 3SBio's stock symbol?

3SBio trades on the NASDAQ under the ticker symbol "SSRX."

How were 3SBio's earnings last quarter?

3SBio Inc (NASDAQ:SSRX) posted its earnings results on Monday, March, 18th. The biotechnology company reported $0.12 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.14 by $0.02. The biotechnology company earned $26.30 million during the quarter, compared to analysts' expectations of $25.63 million. View 3SBio's Earnings History.

Who are some of 3SBio's key competitors?

Who are 3SBio's key executives?

3SBio's management team includes the folowing people:

  • Jing Lou, Executive Chairman of the Board, Chief Executive Officer (Age 54)
  • Bo Tan, Chief Financial Officer, Executive Vice President, Executive Director (Age 44)
  • Fei You, Director - Finance (Age 38)
  • Weihonghas Xiao, Chief Operating Officer (Age 48)
  • Dongmei Su, Senior Vice President, Executive Director (Age 46)
  • Zhenping Zhu MD. Ph.D., Chief Scientific Officer, President - Research & Development (Age 52)
  • Bin Huang, Vice President, Executive Director (Age 56)
  • Xin Ma, Vice President - Human Resources (Age 51)
  • Yongfu Chen, Vice President (Age 60)
  • Kevin Liu, Vice President (Age 47)

Has 3SBio been receiving favorable news coverage?

News headlines about SSRX stock have been trending somewhat positive this week, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. 3SBio earned a daily sentiment score of 0.17 on Accern's scale. They also assigned press coverage about the biotechnology company an impact score of 46.13 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of 3SBio?

Shares of SSRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 3SBio's stock price today?

One share of SSRX stock can currently be purchased for approximately $16.59.

How big of a company is 3SBio?

3SBio has a market capitalization of $366.10 million.

How can I contact 3SBio?

3SBio's mailing address is No. 3 A1, Road 10 Shenyang Economy & Technology Development Zone, SHENYANG, LIA 110027, China. The biotechnology company can be reached via phone at +86-24-25811820.

MarketBeat Community Rating for 3SBio (SSRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  133
MarketBeat's community ratings are surveys of what our community members think about 3SBio and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

3SBio (NASDAQ:SSRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/ABuyBuyBuy
Consensus Rating Score: N/A3.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

3SBio (NASDAQ:SSRX) Consensus Price Target History

Price Target History for 3SBio (NASDAQ:SSRX)

3SBio (NASDAQ:SSRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/20/2017Goldman SachsUpgradeNeutral -> BuyLowView Rating Details
(Data available from 3/22/2016 forward)


3SBio (NASDAQ:SSRX) Earnings History and Estimates Chart

Earnings by Quarter for 3SBio (NASDAQ:SSRX)

3SBio (NASDAQ SSRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/18/2013Q4 2012$0.14$0.12$25.63 million$26.30 millionViewListenView Earnings Details
11/12/2012Q312$0.29$0.15$28.18 million$28.70 millionViewN/AView Earnings Details
8/14/2012Q2 2012$0.24$0.29ViewN/AView Earnings Details
5/13/2012Q1 2012$0.20$0.23ViewN/AView Earnings Details
3/8/2012Q4 2011$0.14$0.16ViewN/AView Earnings Details
11/10/2011Q3 2011$0.23$0.23ViewN/AView Earnings Details
8/15/2011Q2 2011$0.20$0.21ViewN/AView Earnings Details
5/11/2011Q1 2011$0.18$0.15ViewN/AView Earnings Details
3/15/2011Q4 2010$0.06$0.11ViewN/AView Earnings Details
11/15/2010Q3 2010$0.18$0.15ViewN/AView Earnings Details
8/17/2010Q2 2010$0.17$0.17ViewN/AView Earnings Details
5/16/2010Q1 2010$0.16$0.18ViewN/AView Earnings Details
2/11/2010Q4 2009$0.07$0.10ViewN/AView Earnings Details
11/12/2009Q3 2009$0.15$0.18ViewN/AView Earnings Details
8/11/2009Q2 2009$0.13$0.18ViewN/AView Earnings Details
5/19/2009Q1 2009$0.12$0.14ViewN/AView Earnings Details
3/11/2009Q4 2008$0.11$0.08ViewN/AView Earnings Details
11/10/2008Q3 2008$0.14$0.14ViewN/AView Earnings Details
8/12/2008Q2 2008$0.13$0.13ViewN/AView Earnings Details
5/14/2008Q1 2008$0.12$0.13ViewN/AView Earnings Details
2/20/2008Q4 2007$0.13$0.11ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


3SBio (NASDAQ:SSRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for 3SBio (NASDAQ:SSRX)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for 3SBio (NASDAQ SSRX)

No insider trades for this company have been tracked by MarketBeat.com


3SBio (NASDAQ SSRX) News Headlines

Head-To-Head Comparison: Baxalta (BXLT) vs. 3SBio (SSRX)Head-To-Head Comparison: Baxalta (BXLT) vs. 3SBio (SSRX)
www.americanbankingnews.com - February 4 at 1:08 AM
Strongbridge Biopharma (SBBP) vs. 3SBio (SSRX) Head-To-Head ComparisonStrongbridge Biopharma (SBBP) vs. 3SBio (SSRX) Head-To-Head Comparison
www.americanbankingnews.com - January 6 at 7:14 PM
Contrasting 3SBio (SSRX) & KalVista Pharmaceuticals (KALV)Contrasting 3SBio (SSRX) & KalVista Pharmaceuticals (KALV)
www.americanbankingnews.com - December 26 at 11:54 PM
3SBio (SSRX) vs. Kamada (KMDA) Head-To-Head Analysis3SBio (SSRX) vs. Kamada (KMDA) Head-To-Head Analysis
www.americanbankingnews.com - December 26 at 6:18 PM
Head to Head Contrast: Kamada (KMDA) versus 3SBio (SSRX)Head to Head Contrast: Kamada (KMDA) versus 3SBio (SSRX)
www.americanbankingnews.com - December 26 at 5:24 PM
Financial Comparison: 3SBio (SSRX) vs. Its CompetitorsFinancial Comparison: 3SBio (SSRX) vs. Its Competitors
www.americanbankingnews.com - December 3 at 7:30 PM
Contrasting 3SBio (SSRX) & Its CompetitorsContrasting 3SBio (SSRX) & Its Competitors
www.americanbankingnews.com - November 23 at 3:12 PM
Financial Review: 3SBio (SSRX) versus Its RivalsFinancial Review: 3SBio (SSRX) versus Its Rivals
www.americanbankingnews.com - November 6 at 9:25 AM
3SBio (SSRX) and Its Rivals Head-To-Head Survey3SBio (SSRX) and Its Rivals Head-To-Head Survey
www.americanbankingnews.com - November 4 at 1:22 PM

SEC Filings


This page is loading this company's SEC Filings. Please wait...

Social Media


3SBio (NASDAQ:SSRX) Income Statement, Balance Sheet and Cash Flow Statement


3SBio (NASDAQ SSRX) Stock Chart for Thursday, March, 22, 2018

Loading chart…

This page was last updated on 3/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.